Calcium Channel BlockersDirect Renin Inhibitors (DRI) as Novel Antihypertensive Agents

DOI Web Site Web Site 17 References
  • Kasamaki Yuji
    Division of General Medicine, Department of Medicine, Nihon University School of Medicine

Bibliographic Information

Other Title
  • レニン阻害剤
  • レニン ソガイザイ

Search this article

Description

Many clinical studies have been conducted to assess the ability of renin-angiotensin aldosterone system (RAAS) blockade to lower blood pressure and reduce end-organ damage. Direct renin inhibitors (DRI) have emerged as an attractive option to inhibit the RAAS and thus prevent cardiovascular damage. In this review, we examine the data related to the administration of the DRI, aliskiren, as an antihypertensive agent and describe the most recent publications assessing the effects of aliskiren on end-organ protection.

Journal

References(17)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top